Motloch, LJ;,
Jirak, P;,
Gareeva, D;,
Davtyan, P;,
Gumerov, R;,
Lakman, I;,
Tataurov, A;,
Zulkarneev, R;,
Kabirov, I;,
Cai, BZ;,
Valeev, B;,
Pavlov, V;,
Kopp, K;,
Hoppe, UC;,
Lichtenauer, M;,
Fiedler, L;,
Pistulli, R;,
Zagidullin, N (2022) -discharge mortality of patients with COVID-19 pneumonia.
Methods: Serum soluble ST2, VCAM-1, and hs-TnI were
Wu, JN,
Al-Zahrani, A,
Beylerli, O,
Sufianov, R,
Talybov, R,
Meshcheryakova, S,
Sufianova, G,
Gareev, I,
Sufianov, A (2022) -grade gliomas remains poorly known.
Methods: We retrieved published articles from the PubMed, the Cochrane
Nazarova, Liliia Sh.,
Danilko, Ksenia V.,
Malievsky, Viktor A.,
Karimov, Denis O.,
Bakirov, Akhat B.,
Viktorova, Tatyana V. (2022) idiopathic arthritis (JIA). Material and
Methods — The study involved 330 JIA patients and 342 volunteers
Han, Dayong,
Teng, Lei,
Wang, Xiaoxiong,
Zhen, Yunbo,
Chen, Xiaofeng,
Yang, Mingchun,
Gao, Ming,
Yang, Guang,
Han, Mingyang,
Wang, Ligang,
Xu, Jiajun,
Li, Yue,
Shumadalova, Alina,
Zhao, Shiguang (2022) trioxide in newly diagnosed glioma patients is unclear.
Methods: All patients received partial or complete
Fiedler, L.,
Motloch, L.J.,
Jirak, P.,
Gumerov, R.,
Davtyan, P.,
Gareeva, D.,
Lakman, I.,
Tataurov, A.,
Lasinova, G.,
Pavlov, V.,
Hauptmann, L.,
Kopp, K.,
Hoppe, U.C.,
Lichtenauer, M.,
Pistulli, R.,
Dieplinger, A.-M.,
Zagidullin, N. (2022) to be evaluated.
Methods: In this single-center study, admission serum biomarkers of sST-2 and hs-TnI in a single